Suzhou Manufacturing Site
Small Molecule Campus
In Suzhou, we run a 460,000 sq ft commercial-scale small molecule manufacturing base for drug candidates and commercial medicines, with an annual capacity of 600 million tablets and capsules.
Our site is outfitted with industry-leading production equipment, operates a quality management system compliant with global GMP standards, and has secured certifications from US FDA, European EMA, Australian TGA, and China GMP.
Oral Solid Dosage
Flexible Manufacturing Capabilities
- Total 300M Tablet & 300M Capsule Capacity (clinical & commercial)
- Primary Packaging (bottle & blister)
- Label & Packaging
Warehouse
Supports various product types
- Storage Conditions: 15 – 25°C, 2 – 8°C